Background: Recent animal studies show a mechanistic link between intestinal microbial metabolism of dietary phosphatidylcholine and coronary artery disease (CAD) pathogenesis. Levels of the pro-atherosclerotic metabolite trimethylamine-N-oxide, TMAO, are elevated in patients with diabetes mellitus (DM), but their prognostic value remains unclear.
Background: Recent animal studies show a mechanistic link between intestinal microbial metabolism of dietary phosphatidylcholine and coronary artery disease (CAD) pathogenesis. Levels of the pro-atherosclerotic metabolite trimethylamine-N-oxide, TMAO, are elevated in patients with diabetes mellitus (DM), but their prognostic value remains unclear. methods: We examined the relationship between fasting plasma TMAO and incident major adverse cardiac events (MACE=death, myocardial infarction, stroke) over 3-year follow-up in 4,007 stable subjects undergoing elective coronary angiography. conclusion: High plasma TMAO levels, a pro-atherogenic compound formed by gut flora dependent metabolism of the choline group of phosphatidylcholine, portend stronger incident risk of MACE in both diabetics and non-diabetics alike, with modest relationship to glycemic control.
